BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21239736)

  • 1. The activation of leptin-mediated survivin is limited by the inducible suppressor SOCS-3 in MCF-7 cells.
    Palianopoulou M; Papanikolaou V; Stefanou N; Tsezou A
    Exp Biol Med (Maywood); 2011 Jan; 236(1):70-6. PubMed ID: 21239736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells.
    Jiang H; Yu J; Guo H; Song H; Chen S
    Biochem Biophys Res Commun; 2008 Mar; 368(1):1-5. PubMed ID: 18242580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
    Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
    Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis resistance induced by leptin and its mechanism in breast cancer cells].
    Zhao TS; Jiang HP; Wang XC; Ren H; Hao JH
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):651-4. PubMed ID: 20021858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
    Yu JH; Kim KH; Kim H
    Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells.
    Laubner K; Kieffer TJ; Lam NT; Niu X; Jakob F; Seufert J
    Diabetes; 2005 Dec; 54(12):3410-7. PubMed ID: 16306356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
    Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
    BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain stem is a direct target for leptin's action in the central nervous system.
    Hosoi T; Kawagishi T; Okuma Y; Tanaka J; Nomura Y
    Endocrinology; 2002 Sep; 143(9):3498-504. PubMed ID: 12193563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.
    Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of a JAK/STAT pathway inhibitor: cytokine inducible SH2 containing protein in breast cancer.
    Borgés S; Moudilou E; Vouyovitch C; Chiesa J; Lobie P; Mertani H; Raccurt M
    Adv Exp Med Biol; 2008; 617():321-9. PubMed ID: 18497055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leptin promotes the expression of hTERT via STAT3 in breast cancer cells].
    Li SS; Sheng J; Yuan ZN; Wang XC; Zhao TS; Ren H; Hao JH
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2386-8. PubMed ID: 23158658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.
    Knight BB; Oprea-Ilies GM; Nagalingam A; Yang L; Cohen C; Saxena NK; Sharma D
    Endocr Relat Cancer; 2011 Aug; 18(4):413-28. PubMed ID: 21555376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin.
    Yin N; Wang D; Zhang H; Yi X; Sun X; Shi B; Wu H; Wu G; Wang X; Shang Y
    Cancer Res; 2004 Aug; 64(16):5870-5. PubMed ID: 15313931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
    Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
    Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.